M Mohr, A M Jacobi. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh: See more » Antibodies, Monoclonal, Humanized/therapeutic useAntirheumatic Agents/therapeutic useArthritis, Rheumatoid/epidemiologyBronchoalveolar Lavage Fluid/cytologyDrug Therapy, CombinationDyspnea/drug therapyFemaleHumansIsoxazoles/therapeutic useLeflunomideLung Diseases, Interstitial/diagnostic imagingLung Diseases, Interstitial/drug therapyLung Diseases, Interstitial/epidemiologyMethotrexate/therapeutic useMiddle AgedPeptides, Cyclic/antagonists & inhibitorsPeptides, Cyclic/bloodPeptides, Cyclic/immunologyRadiographyReceptors, Interleukin-6/antagonists & inhibitorsRheumatoid Factor/bloodSteroids/therapeutic use
Substances: See more » Antibodies, Monoclonal, HumanizedAntirheumatic AgentsIsoxazolesPeptides, CyclicReceptors, Interleukin-6Steroidscyclic citrullinated peptideRheumatoid FactorLeflunomidetocilizumabMethotrexate
Year: 2011 PMID: 21961704 DOI: 10.3109/03009742.2011.599072
Source DB: PubMed Journal: Scand J Rheumatol ISSN: 0300-9742 Impact factor: 3.641